Evidence map›Paper›PMID 30265667›Full record

ArticlePloS one2018

Who are the male sexual partners of adolescent girls and young women? Comparative analysis of population data in three settings prior to DREAMS roll-out.

Aoife M Doyle, Sian Floyd, Kathy Baisley, Benedict Orindi, Daniel Kwaro, Thandiwe N Mthiyane, Sheru Muuo, Maryam Shahmanesh, Abdhalah Ziraba, Isolde Birdthistle

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Aoife M DoyleMRC Tropical Epidemiology Group, Department of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.ORCID 0000-0002-3305-7738
Sian FloydMRC Tropical Epidemiology Group, Department of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Kathy BaisleyMRC Tropical Epidemiology Group, Department of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Benedict OrindiAfrican Population and Health Research Center, Nairobi, Kenya.
Daniel KwaroKenya Medical Research Institute, Gem, Siaya county, Kenya.
Thandiwe N MthiyaneAfrican Health Research Institute, KwaZulu- Natal, South Africa.
Sheru MuuoAfrican Population and Health Research Center, Nairobi, Kenya.
Maryam ShahmaneshAfrican Health Research Institute, KwaZulu- Natal, South Africa.
Abdhalah ZirabaAfrican Population and Health Research Center, Nairobi, Kenya.
Isolde BirdthistleDepartment of Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
London School of Hygiene & Tropical Medicine · GBAfrican Population and Health Research Center · KEAfrica Health Research Institute · ZAKenya Medical Research Institute · KE

Funding

Maximizing combination HIV prevention, uptake and retention by adolescent girls and young womenR01MH114560 · NIMH · KWAZULU-NATAL RESEARCH INSTITUTE TB-HIV · PI SHAHMANESH, MARYAM · 2017 to 2023
$2.0M
Medical Research Council MR/K012126/1NIMH NIH HHS R01 MH114560Wellcome TrustWellcome Trust 082384/Z/07/ZWellcome Trust GR 07830 M
6 · The paper itself

Abstract

backgroundThe DREAMS (Determined Resilient Empowered AIDS-free, Mentored and Safe) Partnership aims to reduce HIV incidence among adolescent girls and young women (AGYW,15-24y) with a core package of evidence-based interventions. Some interventions, including voluntary HIV counselling and testing and circumcision, will be targeted at the male sexual partners of AGYW. A priority of DREAMS is to characterise the male partners for effective targeting.

methodsUsing population-based data (2010-2015) in three DREAMS impact evaluation settings in Kenya and South Africa, we describe the demographic characteristics and sexual behaviour of male partners reported by AGYW, and the characteristics of males who report sexual activity with AGYW.

resultsIn all settings, over 90% of recent male partners reported by AGYW were aged <35 years. Median ages of spousal and non-spousal partners were 29 and 23 years respectively in uMkhanyakude (rural South Africa) and 21 and 20 years respectively in Nairobi (urban Kenya). Most males reporting an AGYW partner had never been married (89%) and many were in school (39%). Most male partners reported only 1 AGYW partner in the past year; in Gem (rural Kenya) and Nairobi 25%-29% reported 2+(AGYW or older female) partners. Concurrent partners were reported by 16% of male partners in Gem and 3-4% in uMkhanyakude. Two thirds of male partners in Gem reported testing for HIV in the past 6 months and under half in uMkhanyakude reported testing for HIV in the past year. Almost all (96%) partners in Nairobi were circumcised, compared to 45% in Gem and 43% in uMkhanyakude.

conclusionsWith almost all AGYW's sexual partners aged 15-34 years, this is an appropriate target group for DREAMS interventions. Encouraging young men to reduce their number of partners and concurrency, and uptake prevention and treatment services such as HIV testing, circumcision and ART is crucial in the effort to reduce HIV among both AGYW and young men.

Indexed as

Sexual PartnersAdolescentAdultCircumcision, MaleFemaleHIV InfectionsHumansKenyaMaleMarriageRisk FactorsRural PopulationSexual BehaviorSouth AfricaUrban PopulationYoung Adult

Identifiers

PMID30265667
PMCPMC6161870
OpenAlexW2892717271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.